245 related articles for article (PubMed ID: 26329438)
1. Dopaminergic Augmentation in Restless Legs Syndrome/Willis-Ekbom Disease: Identification and Management.
García-Borreguero D
Sleep Med Clin; 2015 Sep; 10(3):287-92, xiii. PubMed ID: 26329438
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.
Garcia-Borreguero D; Benitez A; Kohnen R; Allen R
Postgrad Med; 2015; 127(7):716-25. PubMed ID: 26077324
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
[TBL] [Abstract][Full Text] [Related]
4. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
[TBL] [Abstract][Full Text] [Related]
5. Restless legs syndrome.
Klingelhoefer L; Bhattacharya K; Reichmann H
Clin Med (Lond); 2016 Aug; 16(4):379-82. PubMed ID: 27481386
[TBL] [Abstract][Full Text] [Related]
6. What treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medications.
Hornyak M; Scholz H; Kohnen R; Bengel J; Kassubek J; Trenkwalder C
Sleep Med Rev; 2014 Apr; 18(2):153-64. PubMed ID: 23746768
[TBL] [Abstract][Full Text] [Related]
7. Augmentation as a treatment complication of restless legs syndrome: concept and management.
García-Borreguero D; Allen RP; Benes H; Earley C; Happe S; Högl B; Kohnen R; Paulus W; Rye D; Winkelmann J
Mov Disord; 2007; 22 Suppl 18():S476-84. PubMed ID: 17580331
[TBL] [Abstract][Full Text] [Related]
8. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic augmentation of restless legs syndrome.
García-Borreguero D; Williams AM
Sleep Med Rev; 2010 Oct; 14(5):339-46. PubMed ID: 20219397
[TBL] [Abstract][Full Text] [Related]
10. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
Geyer J; Bogan R
Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
[TBL] [Abstract][Full Text] [Related]
11. Natural course of restless legs syndrome/Willis-Ekbom disease: long-term observation of a large clinical cohort.
Mitterling T; Heidbreder A; Stefani A; Fritz J; Ulmer H; Poewe W; Högl B
Sleep Med; 2015 Oct; 16(10):1252-8. PubMed ID: 26429754
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatments of augmentation in restless legs syndrome patients.
Trenkwalder C; Paulus W
Adv Pharmacol; 2019; 84():255-265. PubMed ID: 31229175
[TBL] [Abstract][Full Text] [Related]
13. Pharmacologic Treatment of Restless Legs Syndrome.
Lv Q; Wang X; Asakawa T; Wang XP
Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
[TBL] [Abstract][Full Text] [Related]
15. New concepts in the management of restless legs syndrome.
Garcia-Borreguero D; Cano-Pumarega I
BMJ; 2017 Feb; 356():j104. PubMed ID: 28242627
[TBL] [Abstract][Full Text] [Related]
16. Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome.
Paulus W; Trenkwalder C
Lancet Neurol; 2006 Oct; 5(10):878-86. PubMed ID: 16987735
[TBL] [Abstract][Full Text] [Related]
17. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges.
Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L
Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315
[TBL] [Abstract][Full Text] [Related]
18. Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).
Rinaldi F; Galbiati A; Marelli S; Ferini Strambi L; Zucconi M
Curr Treat Options Neurol; 2016 Feb; 18(2):7. PubMed ID: 26874840
[TBL] [Abstract][Full Text] [Related]
19. Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.
Mackie S; Winkelman JW
CNS Drugs; 2015 May; 29(5):351-7. PubMed ID: 26045290
[TBL] [Abstract][Full Text] [Related]
20. Restless legs syndrome: treatment with dopaminergic agents.
Comella CL
Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
